Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

G. Hudes, M. Carducci, P. Tomczak, J. Dutcher, R. Figlin, A. Kapoor, E. Staroslawska, J. Sosman, D. McDermott, I. Bodrogi, Z. Kovacevic, V. Lesovoy, I. G. Schmidt-Wolf, O. Barbarash, E. Gokmen, T. O'Toole, S. Lustgarten, L. Moore, R. J. Motzer

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)497-498
Number of pages2
JournalJournal of Urology
Volume179
Issue number2
DOIs
StatePublished - Feb 2008

ASJC Scopus subject areas

  • Urology

Cite this

Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., Kovacevic, Z., Lesovoy, V., Schmidt-Wolf, I. G., Barbarash, O., Gokmen, E., O'Toole, T., Lustgarten, S., Moore, L., & Motzer, R. J. (2008). Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Journal of Urology, 179(2), 497-498. https://doi.org/10.1016/j.juro.2007.10.039